Literature DB >> 6115618

DTIC (dacarbazine)-induced hepatic damage. Possible pathogenesis and prevention.

B M Czarnetzki, E Macher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6115618     DOI： 10.1007/bf00403944

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  2 in total

1.  [Budd-Chiari syndrome during treatment with dacarbazine (DTIC) (author's transl)].

Authors:  U Runne; K Doepfmer; H Antz; W Groth; W FEAUX DE Lacroix
Journal:  Dtsch Med Wochenschr       Date:  1980-02-15       Impact factor: 0.628

2.  Hepatic failure in a patient treated with dacarbazine (DTIC) for malignant melanoma.

Authors:  P J Frosch; B M Czarnetzki; E Macher; E Grundmann; I Gottschalk
Journal:  J Cancer Res Clin Oncol       Date:  1979       Impact factor: 4.553
  2 in total
  1 in total

1.  Mechanisms of hepatotoxicity caused by dacarbazine in rats.

Authors:  R Paschke; M Heine; S Braun; K H Usadel
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.